Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Investigation of the role of Chrna4-expressing hepatocytes in liver regeneration following acute and chronic liver injury.
FY 2025-26
Summary
Liver disorders are a leading cause of human disease and death globally. Treatment often involves surgical removal of damaged liver tissue and/or liver transplantation, both of which require normal liver cells (mostly hepatocytes) to multiply and restore function in a process called “liver regeneration” (LR). The neurotransmitter acetylcholine (ACh) is essential for LR. Although ACh is primarily known for its role in the nervous system, it can also be secreted by immune cells (B and T cells) to regulate various cell types within the liver. However, despite the identification of several ACh receptors (AChRs) on hepatocyte surfaces, how the binding of ACh to AChRs contributes to LR is unknown. My proposal seeks to use genetically engineered mouse models to answer this question. Our early results in mice indicate that expression of the Chrna4 gene encoding a critical AChR increases on hepatocytes that start replicating after liver damage. I will study LR and liver disease development using mutant mice in which hepatocytes have lost Chrna4 expression, meaning that they no longer have this receptor on their surfaces and cannot conduct ACh signalling. I will induce acute liver damage via “partial hepatectomy”, a surgical method that removes 70% of the liver. I will also induce chronic liver injury by ligating the bile ducts of mice fed on a high-fat diet. By subjecting various strains of mutant mice (and controls) to these procedures, I will determine the source of the ACh that binds to Chrna4 receptors on hepatocytes and activates their growth during LR. This research will aid us in understanding how ACh produced by immune cells influences hepatocytes and LR. My findings may point to new therapeutics that could improve the lives of patients suffering from liver diseases.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572996
Name
Pan Maxwell
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigation of the role of Chrna4-expressing hepatocytes in liver regeneration following acute and chronic liver injury.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Acetylcholine; Cell Biology; Hepatology; Immunology; Liver Disease; Liver Regeneration; Neuroregulation
Abstract
Liver disorders are a leading cause of human disease and death globally. Treatment often involves surgical removal of damaged liver tissue and/or liver transplantation, both of which require normal liver cells (mostly hepatocytes) to multiply and restore function in a process called “liver regeneration” (LR). The neurotransmitter acetylcholine (ACh) is essential for LR. Although ACh is primarily known for its role in the nervous system, it can also be secreted by immune cells (B and T cells) to regulate various cell types within the liver. However, despite the identification of several ACh receptors (AChRs) on hepatocyte surfaces, how the binding of ACh to AChRs contributes to LR is unknown. My proposal seeks to use genetically engineered mouse models to answer this question. Our early results in mice indicate that expression of the Chrna4 gene encoding a critical AChR increases on hepatocytes that start replicating after liver damage. I will study LR and liver disease development using mutant mice in which hepatocytes have lost Chrna4 expression, meaning that they no longer have this receptor on their surfaces and cannot conduct ACh signalling. I will induce acute liver damage via “partial hepatectomy”, a surgical method that removes 70% of the liver. I will also induce chronic liver injury by ligating the bile ducts of mice fed on a high-fat diet. By subjecting various strains of mutant mice (and controls) to these procedures, I will determine the source of the ACh that binds to Chrna4 receptors on hepatocytes and activates their growth during LR. This research will aid us in understanding how ACh produced by immune cells influences hepatocytes and LR. My findings may point to new therapeutics that could improve the lives of patients suffering from liver diseases.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pan, Maxwell
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~